img

Global Pet Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pet Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pet Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pet Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Canine and Avian are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pet Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pet Vaccine key manufacturers include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Pet Vaccine can be divided into Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines and Subunit Vaccines, etc. Attenuated Live Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Pet Vaccine is widely used in various fields, such as Canine, Avian and Feline,, etc. Canine provides greatest supports to the Pet Vaccine industry development. In 2022, global % sales of Pet Vaccine went into Canine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines

Segment by Application


Canine
Avian
Feline

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pet Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pet Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pet Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pet Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pet Vaccine introduction, etc. Pet Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pet Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pet Vaccine Market Overview
1.1 Pet Vaccine Product Overview
1.2 Pet Vaccine Market Segment by Type
1.2.1 Attenuated Live Vaccines
1.2.2 Conjugate Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Toxoid Vaccines
1.2.6 DNA Vaccines
1.2.7 Recombinant Vaccines
1.3 Global Pet Vaccine Market Size by Type
1.3.1 Global Pet Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Pet Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pet Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pet Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pet Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pet Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pet Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pet Vaccine Sales Breakdown by Type (2018-2024)
2 Global Pet Vaccine Market Competition by Company
2.1 Global Top Players by Pet Vaccine Sales (2018-2024)
2.2 Global Top Players by Pet Vaccine Revenue (2018-2024)
2.3 Global Top Players by Pet Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Pet Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pet Vaccine Market Competitive Situation and Trends
2.5.1 Pet Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pet Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Pet Vaccine Market
2.8 Key Manufacturers Pet Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pet Vaccine Status and Outlook by Region
3.1 Global Pet Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pet Vaccine Historic Market Size by Region
3.2.1 Global Pet Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Pet Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Pet Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pet Vaccine Forecasted Market Size by Region
3.3.1 Global Pet Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Pet Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Pet Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pet Vaccine by Application
4.1 Pet Vaccine Market Segment by Application
4.1.1 Canine
4.1.2 Avian
4.1.3 Feline
4.2 Global Pet Vaccine Market Size by Application
4.2.1 Global Pet Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Pet Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pet Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pet Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pet Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pet Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pet Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pet Vaccine Sales Breakdown by Application (2018-2024)
5 North America Pet Vaccine by Country
5.1 North America Pet Vaccine Historic Market Size by Country
5.1.1 North America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pet Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Pet Vaccine Sales in Value by Country (2018-2024)
5.2 North America Pet Vaccine Forecasted Market Size by Country
5.2.1 North America Pet Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Pet Vaccine Sales in Value by Country (2024-2034)
6 Europe Pet Vaccine by Country
6.1 Europe Pet Vaccine Historic Market Size by Country
6.1.1 Europe Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pet Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Pet Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Pet Vaccine Forecasted Market Size by Country
6.2.1 Europe Pet Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Pet Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Pet Vaccine by Region
7.1 Asia-Pacific Pet Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Pet Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pet Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pet Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pet Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Pet Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pet Vaccine Sales in Value by Region (2024-2034)
8 Latin America Pet Vaccine by Country
8.1 Latin America Pet Vaccine Historic Market Size by Country
8.1.1 Latin America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pet Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pet Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Pet Vaccine Forecasted Market Size by Country
8.2.1 Latin America Pet Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pet Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Pet Vaccine by Country
9.1 Middle East and Africa Pet Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pet Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pet Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pet Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Pet Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pet Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Company Information
10.1.2 Bayer Healthcare Introduction and Business Overview
10.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Healthcare Pet Vaccine Products Offered
10.1.5 Bayer Healthcare Recent Development
10.2 Vetoquinol S.A
10.2.1 Vetoquinol S.A Company Information
10.2.2 Vetoquinol S.A Introduction and Business Overview
10.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Vetoquinol S.A Pet Vaccine Products Offered
10.2.5 Vetoquinol S.A Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Pet Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Introduction and Business Overview
10.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ceva Pet Vaccine Products Offered
10.4.5 Ceva Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli Lilly Pet Vaccine Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Heska Co.
10.6.1 Heska Co. Company Information
10.6.2 Heska Co. Introduction and Business Overview
10.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Heska Co. Pet Vaccine Products Offered
10.6.5 Heska Co. Recent Development
10.7 Merck Animal Health
10.7.1 Merck Animal Health Company Information
10.7.2 Merck Animal Health Introduction and Business Overview
10.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck Animal Health Pet Vaccine Products Offered
10.7.5 Merck Animal Health Recent Development
10.8 Merial (Sanofi)
10.8.1 Merial (Sanofi) Company Information
10.8.2 Merial (Sanofi) Introduction and Business Overview
10.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merial (Sanofi) Pet Vaccine Products Offered
10.8.5 Merial (Sanofi) Recent Development
10.9 Virbac
10.9.1 Virbac Company Information
10.9.2 Virbac Introduction and Business Overview
10.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Virbac Pet Vaccine Products Offered
10.9.5 Virbac Recent Development
10.10 Zoetis (Pfizer)
10.10.1 Zoetis (Pfizer) Company Information
10.10.2 Zoetis (Pfizer) Introduction and Business Overview
10.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered
10.10.5 Zoetis (Pfizer) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pet Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pet Vaccine Industrial Chain Analysis
11.4 Pet Vaccine Market Dynamics
11.4.1 Pet Vaccine Industry Trends
11.4.2 Pet Vaccine Market Drivers
11.4.3 Pet Vaccine Market Challenges
11.4.4 Pet Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pet Vaccine Distributors
12.3 Pet Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Attenuated Live Vaccines
Table 2. Major Company of Conjugate Vaccines
Table 3. Major Company of Inactivated Vaccines
Table 4. Major Company of Subunit Vaccines
Table 5. Major Company of Toxoid Vaccines
Table 6. Major Company of DNA Vaccines
Table 7. Major Company of Recombinant Vaccines
Table 8. Global Pet Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Pet Vaccine Sales by Type (2018-2024) & (K Doses)
Table 10. Global Pet Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Pet Vaccine Sales by Type (2018-2024) & (US& Million)
Table 12. Global Pet Vaccine Market Share in Value by Type (2018-2024)
Table 13. Global Pet Vaccine Price by Type (2018-2024) & (USD/Dose)
Table 14. Global Pet Vaccine Sales by Type (2024-2034) & (K Doses)
Table 15. Global Pet Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Pet Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Pet Vaccine Sales Market Share in Value by Type (2024-2034)
Table 18. Global Pet Vaccine Price by Type (2024-2034) & (USD/Dose)
Table 19. North America Pet Vaccine Sales by Type (2018-2024) & (K Doses)
Table 20. North America Pet Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Pet Vaccine Sales (K Doses) by Type (2018-2024)
Table 22. Europe Pet Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Pet Vaccine Sales (K Doses) by Type (2018-2024)
Table 24. Asia-Pacific Pet Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Pet Vaccine Sales (K Doses) by Type (2018-2024)
Table 26. Latin America Pet Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Pet Vaccine Sales (K Doses) by Type (2018-2024)
Table 28. Middle East and Africa Pet Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Pet Vaccine Sales by Company (2018-2024) & (K Doses)
Table 30. Global Pet Vaccine Sales Share by Company (2018-2024)
Table 31. Global Pet Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Pet Vaccine Revenue Share by Company (2018-2024)
Table 33. Global Market Pet Vaccine Price by Company (2018-2024) & (USD/Dose)
Table 34. Global Pet Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Vaccine as of 2022)
Table 37. Date of Key Manufacturers Enter into Pet Vaccine Market
Table 38. Key Manufacturers Pet Vaccine Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Pet Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Pet Vaccine Sales by Region (2018-2024) & (K Doses)
Table 42. Global Pet Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Pet Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Pet Vaccine Sales Market Share in Value by Region (2018-2024)
Table 45. Global Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 46. Global Pet Vaccine Sales by Region (2024-2034) & (K Doses)
Table 47. Global Pet Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Pet Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Pet Vaccine Sales Market Share in Value by Region (2024-2034)
Table 50. Global Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 51. Global Pet Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Pet Vaccine Sales by Application (2018-2024) & (K Doses)
Table 53. Global Pet Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Pet Vaccine Sales Market Share in Value by Application (2018-2024)
Table 56. Global Pet Vaccine Price by Application (2018-2024) & (USD/Dose)
Table 57. Global Pet Vaccine Sales by Application (2024-2034) & (K Doses)
Table 58. Global Pet Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Pet Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Pet Vaccine Sales Market Share in Value by Application (2024-2034)
Table 61. Global Pet Vaccine Price by Application (2024-2034) & (USD/Dose)
Table 62. North America Pet Vaccine Sales by Application (2018-2024) (K Doses)
Table 63. North America Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Pet Vaccine Sales by Application (2018-2024) (K Doses)
Table 65. Europe Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Pet Vaccine Sales by Application (2018-2024) (K Doses)
Table 67. Asia-Pacific Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Pet Vaccine Sales by Application (2018-2024) (K Doses)
Table 69. Latin America Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Pet Vaccine Sales by Application (2018-2024) (K Doses)
Table 71. Middle East and Africa Pet Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Pet Vaccine Sales by Country (2018-2024) & (K Doses)
Table 73. North America Pet Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Pet Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Pet Vaccine Sales Market Share in Value by Country (2018-2024)
Table 76. North America Pet Vaccine Sales by Country (2024-2034) & (K Doses)
Table 77. North America Pet Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Pet Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Pet Vaccine Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Pet Vaccine Sales by Country (2018-2024) & (K Doses)
Table 81. Europe Pet Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Pet Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Pet Vaccine Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Pet Vaccine Sales by Country (2024-2034) & (K Doses)
Table 85. Europe Pet Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Pet Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Pet Vaccine Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Pet Vaccine Sales by Region (2018-2024) & (K Doses)
Table 89. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Pet Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Pet Vaccine Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Pet Vaccine Sales by Region (2024-2034) & (K Doses)
Table 93. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Pet Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Pet Vaccine Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Pet Vaccine Sales by Country (2018-2024) & (K Doses)
Table 97. Latin America Pet Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Pet Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Pet Vaccine Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Pet Vaccine Sales by Country (2024-2034) & (K Doses)
Table 101. Latin America Pet Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Pet Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Pet Vaccine Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Pet Vaccine Sales by Country (2018-2024) & (K Doses)
Table 105. Middle East and Africa Pet Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Pet Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Pet Vaccine Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Pet Vaccine Sales by Country (2024-2034) & (K Doses)
Table 109. Middle East and Africa Pet Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Pet Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Pet Vaccine Sales Market Share in Value by Country (2024-2034)
Table 112. Bayer Healthcare Company Information
Table 113. Bayer Healthcare Introduction and Business Overview
Table 114. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. Bayer Healthcare Pet Vaccine Product
Table 116. Bayer Healthcare Recent Development
Table 117. Vetoquinol S.A Company Information
Table 118. Vetoquinol S.A Introduction and Business Overview
Table 119. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Vetoquinol S.A Pet Vaccine Product
Table 121. Vetoquinol S.A Recent Development
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Introduction and Business Overview
Table 124. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 125. Boehringer Ingelheim Pet Vaccine Product
Table 126. Boehringer Ingelheim Recent Development
Table 127. Ceva Company Information
Table 128. Ceva Introduction and Business Overview
Table 129. Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 130. Ceva Pet Vaccine Product
Table 131. Ceva Recent Development
Table 132. Eli Lilly Company Information
Table 133. Eli Lilly Introduction and Business Overview
Table 134. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 135. Eli Lilly Pet Vaccine Product
Table 136. Eli Lilly Recent Development
Table 137. Heska Co. Company Information
Table 138. Heska Co. Introduction and Business Overview
Table 139. Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 140. Heska Co. Pet Vaccine Product
Table 141. Heska Co. Recent Development
Table 142. Merck Animal Health Company Information
Table 143. Merck Animal Health Introduction and Business Overview
Table 144. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 145. Merck Animal Health Pet Vaccine Product
Table 146. Merck Animal Health Recent Development
Table 147. Merial (Sanofi) Company Information
Table 148. Merial (Sanofi) Introduction and Business Overview
Table 149. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 150. Merial (Sanofi) Pet Vaccine Product
Table 151. Merial (Sanofi) Recent Development
Table 152. Virbac Company Information
Table 153. Virbac Introduction and Business Overview
Table 154. Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 155. Virbac Pet Vaccine Product
Table 156. Virbac Recent Development
Table 157. Zoetis (Pfizer) Company Information
Table 158. Zoetis (Pfizer) Introduction and Business Overview
Table 159. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 160. Zoetis (Pfizer) Pet Vaccine Product
Table 161. Zoetis (Pfizer) Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Pet Vaccine Market Trends
Table 165. Pet Vaccine Market Drivers
Table 166. Pet Vaccine Market Challenges
Table 167. Pet Vaccine Market Restraints
Table 168. Pet Vaccine Distributors List
Table 169. Pet Vaccine Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Vaccine Product Picture
Figure 2. Global Pet Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pet Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pet Vaccine Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Attenuated Live Vaccines
Figure 6. Global Attenuated Live Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Conjugate Vaccines
Figure 8. Global Conjugate Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of Inactivated Vaccines
Figure 10. Global Inactivated Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Product Picture of Subunit Vaccines
Figure 12. Global Subunit Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 13. Product Picture of Toxoid Vaccines
Figure 14. Global Toxoid Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 15. Product Picture of DNA Vaccines
Figure 16. Global DNA Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 17. Product Picture of Recombinant Vaccines
Figure 18. Global Recombinant Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 19. Global Pet Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Pet Vaccine Sales Market Share by Type in 2022 & 2034
Figure 21. North America Pet Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. North America Pet Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Europe Pet Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Europe Pet Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Pet Vaccine Sales Market Share in Value by Type in 2022
Figure 27. Latin America Pet Vaccine Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Pet Vaccine Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Pet Vaccine Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Pet Vaccine Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Vaccine Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Vaccine Revenue in 2022
Figure 33. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Canine
Figure 35. Global Canine Sales YoY Growth (2018-2034) & (K Doses)
Figure 36. Product Picture of Avian
Figure 37. Global Avian Sales YoY Growth (2018-2034) & (K Doses)
Figure 38. Product Picture of Feline
Figure 39. Global Feline Sales YoY Growth (2018-2034) & (K Doses)
Figure 40. Global Pet Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Pet Vaccine Sales Market Share by Application in 2022 & 2034
Figure 42. North America Pet Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. North America Pet Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Europe Pet Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Europe Pet Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Pet Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Latin America Pet Vaccine Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Pet Vaccine Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Pet Vaccine Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Pet Vaccine Manufacturing Cost Structure
Figure 53. Pet Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries